Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 18, 2013

In re Dynavax Technologies Corporation Securities Litigation

Track this case

Case Number:

3:13-cv-02796

Court:

California Northern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Charles R. Breyer

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 19, 2013

    Dynavax Accused Of Duping Investors About Hepatitis Vaccine

    Dynavax Technologies Corp. investors hit the biopharmaceutical company with a putative class action Tuesday alleging it made false statements about its Heplisav vaccine for hepatitis B, causing its share price to plunge after it disclosed that regulators had safety concerns.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login